α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

SUMMARY α-Synuclein aggregation is a hallmark of Parkinson’s disease and related synucleinopathies. Extracellular α-synuclein fibrils enter naïve cells via endocytosis, followed by transit into the cytoplasm to seed endogenous α-synuclein aggregation. Intracellular aggregates sequester numerous proteins, including subunits of the ESCRT-III system for endolysosome membrane repair, but the toxic effects of these events remain poorly understood. Using cellular models and in vitro reconstitution, we found that α-synuclein fibrils interact with an α-helix common to ESCRT-III proteins. This interaction results in sequestration of ESCRT-III subunits and triggers their proteasomal destruction in a process of “collateral degradation.” These twin mechanisms deplete the available ESCRT-III pool, initiating a toxic feedback loop. The ensuing loss of ESCRT function compromises endolysosome membranes, thereby facilitating escape of aggregate seeds into the cytoplasm, which in turn increases aggregation and ESCRT-III sequestration. We suggest that collateral degradation and triggering of self-perpetuating systems could be general mechanisms of sequestration-induced proteotoxicity. HIGHLIGHTS α-Synuclein fibrils bind and sequester ESCRT-III endolysosome repair proteins An α-helical segment common to ESCRT-III mediates fibril-selective interaction Fibril-bound ESCRT-III subunits undergo “collateral degradation” via the proteasome ESCRT-III depletion damages endolysosomes and worsens α-synuclein aggregation

Related topics